Crystal Nucleus is a biopharmaceutical research and development company. The company is mainly engaged in medical research and experimental development (except human stem cells, gene diagnosis and treatment technology development and application), and drug commissioned production. Crystal Nucleus recently completed an angel round of financing of nearly RMB 100 million. The lead investor in this round is Gaorong Capital, followed by VI Ventures, Lichen Capital and old shareholder Kaitai Capital.
This article is reproduced from: https://www.itjuzi.com/investevent/13335813
This site is for inclusion only, and the copyright belongs to the original author.